Majocchi's granuloma caused by Trichophyton rubrum after facial injection with hyaluronic acid: A case report
Authors:
- Jie LiuJLJie Liu
- Wen-Qiang XinWXWen-Qiang Xin
- Lan-Ting LiuLLLan-Ting Liu
- Chao-Feng ChenCCChao-Feng Chen
- Lin WuLWLin Wu
- Xiao-Ping HuXHXiao-Ping Hu
Open Access
- 6 September 2020
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 8 (17) , 3853-3858
Abstract
Facial cosmetic procedures become popular for people with a desire to have a younger appearance, and cosmetic technology has developed rapidly over the past several decades. However, increasing complications related to cosmetic injections have been reported, and infection is one of the most serious problems and can cause anxiety and facial injury. We here report a case of Majocchi's granuloma (MG) caused by Trichophyton rubrum after facial injection of hyaluronic acid. A 37-year-old woman presented to our hospital with a history of red papules, nodules, and abscesses on her left zygomatic arch for 2 mo. She had received a cosmetic injection of hyaluronic acid on the left side of her face prior to the appearance of the lesions. MG caused by Trichophyton rubrum after facial injection of hyaluronic acid was diagnosed based on morphology and molecular biological identification. In vitro antifungal susceptibility testing was conducted according to the Clinical and Laboratory Standards Institute M38-A2 method. Minimal inhibitory concentrations were used to evaluate the antifungal susceptibility. The antifungal agents and their minimal inhibitory concentrations for the strain were terbinafine (< 0.5 μg/mL), itraconazole (0.06 μg/mL), amphotericin B (0.25 μg/mL), fluconazole (32 μg/mL), voriconazole (0.125 μg/mL), posaconazole (0.125 μg/mL), and isavuconazole (0.06 μg/mL). We initially administered 250 mg/d oral terbinafine for 2 mo, but the patient still had painful papules, nodules and abscesses on her face. Then, we adjusted the treatment to itraconazole 400 mg/d for 8 wk based on the in vitro antifungal susceptibility testing results. The skin lesions improved significantly, and there was no recurrence during follow-up. This case revealed that facial injection of hyaluronic acid may cause serious MG. Antifungal susceptibility testing should be considered in the treatment of MG caused by Trichophyton rubrum.Keywords
This publication has 20 references indexed in Scilit:
- Pubic Majocchi's Granuloma Unresponsive to Itraconazole Successfully Treated with Oral TerbinafineSkin Appendage Disorders, 2015
- Management von Komplikationen nach ästhetischen HyaluronsäureinjektionenDie Dermatologie, 2014
- Complications Following Injection of Soft-Tissue FillersAesthetic Surgery Journal, 2013
- Majocchi's granuloma: a symptom complex caused by fungal pathogensMedical Mycology, 2012
- Complications of Hyaluronic Acid FillersFacial Plastic Surgery, 2009
- Advances in minimally invasive facial rejuvenationCurrent Opinion in Otolaryngology & Head and Neck Surgery, 2008
- Amino Acid Substitution inTrichophyton rubrumSqualene Epoxidase Associated with Resistance to TerbinafineAntimicrobial Agents and Chemotherapy, 2005
- Biochemical characterization of terbinafine-resistantTrichophytonrubrumisolatesMedical Mycology, 2004
- Clinical Trichophyton rubrum Strain Exhibiting Primary Resistance to TerbinafineAntimicrobial Agents and Chemotherapy, 2003
- Hyaluronic acid skin fillers: Adverse reactions and skin testingJournal of the American Academy of Dermatology, 2001